RG

Ravi Gendalal Mewade

Active Director Designated Partner DIN 09147250
DIN 09147250 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Gendalal Mewade

Data last updated:

Ravi Gendalal Mewade is a Designated Partner at Purple Mark Pharmaceuticals Llp (since 2021). The company operates in Chemicals.

DIN 09147250
Primary Designation Designated Partner
Industry Chemicals
First Appointment 15 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Apr 20212021Active

Board colleagues of Ravi Gendalal Mewade

NameDINCompanyDesignation
Ritesh Mewade09147251Purple Mark Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Purple Mark Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Ravi Gendalal Mewade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Gendalal Mewade

Ravi Gendalal Mewade currently holds 1 directorship: Purple Mark Pharmaceuticals Llp (Designated Partner, since 15 Apr 2021).

Ravi Gendalal Mewade was first appointed on 15 Apr 2021 as Designated Partner at Purple Mark Pharmaceuticals Llp.

The current boards of Ravi Gendalal Mewade's companies include Ritesh Mewade (Purple Mark Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available